Matthew Galsky, MD

Clinical Focus

• Bladder Cancer
• Kidney Cancer
• Primary Pulmonary Hypertension
• Prostate Cancer
• Testicular Cancer
• Testicular Tumors
• Urologic Cancers

• Bladder Cancer
• Kidney Cancer
• Primary Pulmonary Hypertension
• Prostate Cancer
• Testicular Cancer
• Testicular Tumors
• Urologic Cancers

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, 3rd Floor, New York, NY, 10029

212-241-6756

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials. Julia Blanter, Grace Van Hyfte, Maham Ahmad, Suzanne Xu, Olivia Hapanowicz, Gabriela Fazilov, Ashley Lu, Natalie Lucas, Kathy Wu, Gary Shelton, Mandy Demerchant, Michael Lachowicz, Melanie Kier, Michael Werner, Joseph P. Eder, Matthew D. Galsky, Thomas U. Marron, Cardinale B. Smith, Patricia M. Lorusso, Erin Hofstatter, Deborah B. Doroshow. JCO Oncology Practice
• Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate Radiation Therapy. Daniel R. Dickstein, Thodori Kapouranis, Keith Sigel, Christopher W. Wheldon, Eva Nvepu, Noelle Marie Javier, Robert Stewart, Matthew Galsky, John Sfakianos, Joshua D. Safer, Richard Stock, Karyn Goodman, B. R.Simon Rosser, Kathryn E. Flynn, Deborah C. Marshall. International Journal of Radiation Oncology Biology Physics
• Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study. Shilpa Gupta, Yohann Loriot, Michiel S. Van der Heijden, Jens Bedke, Begoña P. Valderrama, Eiji Kikuchi, Aude Fléchon, Daniel Petrylak, Maria De Santis, Matthew D. Galsky, Jae Lyun Lee, Umang Swami, Srikala S. Sridhar, Ugo De Giorgi, Phoebe Wright, Vanessa Shih, Yi Tsung Lu, Xuesong Guan, Ryan Dillon, Aditya Shetty, Blanca Homet Moreno, Jennifer L. Beaumont, Intan Purnajo, Shauna McManus, Thomas Powles. The Lancet Oncology

Industry Relationships